Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
10.19
+0.12 (1.19%)
Feb 25, 2026, 10:13 AM EST - Market open
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $186.93 million as of February 25, 2026. Its market cap has increased by 136.31% in one year.
Market Cap
186.93M
Enterprise Value
428.21M
1-Year Change
136.31%
Ranking
Category
Stock Price
$10.19
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $186.93M, a decrease of -57.80%. That is a compound annual growth rate of -6.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 184.70M | 47.17% |
| Dec 31, 2025 | 125.50M | 48.17% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
| Nov 6, 2013 | 442.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 187.02M |
| Canton Strategic Holdings | 185.00M |
| Cartesian Therapeutics | 180.20M |
| Tonix Pharmaceuticals Holding | 179.63M |
| Molecular Partners AG | 178.48M |
| Editas Medicine | 174.74M |
| Eledon Pharmaceuticals | 173.78M |
| Sagimet Biosciences | 173.01M |